For: | Luis M, Tavares A, Carvalho LS, Lara-Santos L, Araújo A, Mello RA. Personalizing therapies for gastric cancer: Molecular mechanisms and novel targeted therapies. World J Gastroenterol 2013; 19(38): 6383-6397 [PMID: 24151357 DOI: 10.3748/wjg.v19.i38.6383] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i38/6383.htm |
Number | Citing Articles |
1 |
Yujing Zhou, Chunhua Liu, Yongcan Huang. Wireless Power Transfer for Implanted Medical Application: A Review. Energies 2020; 13(11): 2837 doi: 10.3390/en13112837
|
2 |
Onur CEYLAN, Sevilay ÖZMEN. Prognostic Significance of HER-2 Expression in Gastric Cancer. Black Sea Journal of Health Science 2021; 4(2): 52 doi: 10.19127/bshealthscience.836510
|
3 |
Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, Daniel Humberto Pozza, Louis Vermeulen, Sofia Palacio, Matthew Salzberg, A. Craig Lockhart. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?. American Society of Clinical Oncology Educational Book 2018; (38): 249 doi: 10.1200/EDBK_198805
|
4 |
Julie Giraud, Silvia Molina‐Castro, Lornella Seeneevassen, Elodie Sifré, Julien Izotte, Camille Tiffon, Cathy Staedel, Hélène Boeuf, Solène Fernandez, Philippe Barthelemy, Francis Megraud, Philippe Lehours, Pierre Dubus, Christine Varon. Verteporfin targeting YAP1/TAZ‐TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. International Journal of Cancer 2020; 146(8): 2255 doi: 10.1002/ijc.32667
|
5 |
Hongbo Zhou, Ailian Dong, Hui Xia, Guangmei He, Jianghe Cui. Associations between CA19‑9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8731
|
6 |
Yasuhiro Oono, Takeshi Kuwata, Kenji Takashima, Kensuke Shinmura, Keisuke Hori, Yusuke Yoda, Hiroaki Ikematsu, Kohei Shitara, Takahiro Kinoshita, Tomonori Yano. Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples. Gastric Cancer 2019; 22(2): 335 doi: 10.1007/s10120-018-0853-7
|
7 |
SU-QING ZHANG, KE-KANG SUN, XIAO-YANG WU, NING ZHONG, HUA ZHAO, DE-CHUN LI. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer. Molecular Medicine Reports 2015; 12(1): 1177 doi: 10.3892/mmr.2015.3470
|
8 |
Pedro Nazareth Aguiar, Thiago Pimentel Muniz, Raelson Rodrigues Miranda, Hakaru Tadokoro, Nora Manoukian Forones, Ines-de-Paula Monteiro, Pedro Castelo-Branco, Yelena Y Janjigian, Ramon Andrade de Mello. Current Advances in Targeted Therapies for Metastatic Gastric Cancer: Improving Patient Care. Future Oncology 2016; 12(6): 839 doi: 10.2217/fon.15.348
|
9 |
Zijun Guo, Lin Guo. Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression. International Journal of Clinical Oncology 2024; 29(4): 442 doi: 10.1007/s10147-024-02478-3
|
10 |
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
Abstract(293) |
Core Tip(318) |
Full Article(HTML)(1455)
|
Full Article with Cover (PDF)-10337K(51)
|
Audio-441K(3)
|
Peer-Review Report-231K(31)
|
Answering Reviewers-70K(30)
|
Supplementary Material-8723K(36)
|
Full Article (PDF)-10027K(82)
|
Full Article (XML)-321K(38)
|
Times Cited (0)
|
Total Visits (2879)
|
Open
|
11 |
Jian He, Hua Shi, Zhuping Zhou, Jun Chen, Wenxian Guan, Hao Wang, Haiping Yu, Song Liu, Zhengyang Zhou, Xiaofeng Yang, Tian Liu. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1726-7
|
12 |
Phu Hung Nguyen, Julie Giraud, Lucie Chambonnier, Pierre Dubus, Linda Wittkop, Geneviève Belleannée, Denis Collet, Isabelle Soubeyran, Serge Evrard, Benoit Rousseau, Nathalie Senant-Dugot, Francis Mégraud, Frédéric Mazurier, Christine Varon. Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma. Clinical Cancer Research 2017; 23(6): 1586 doi: 10.1158/1078-0432.CCR-15-2157
|
13 |
Gretel Terrero, A. Craig Lockhart. Role of Immunotherapy in Advanced Gastroesophageal Cancer. Current Oncology Reports 2020; 22(11) doi: 10.1007/s11912-020-00975-y
|
14 |
Xin-Yuan Liu, Tian-Qi Zhang, Qi Zhang, Jing Guo, Peng Zhang, Tao Mao, Zi-Bin Tian, Cui-Ping Zhang, Xiao-Yu Li. Differential Long Non-Coding RNA Expression Analysis in Chronic Non-Atrophic Gastritis, Gastric Mucosal Intraepithelial Neoplasia, and Gastric Cancer Tissues. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.833857
|
15 |
Sadeque Reza Khan, Sumanth Kumar Pavuluri, Gerard Cummins, Marc P. Y. Desmulliez. Wireless Power Transfer Techniques for Implantable Medical Devices: A Review. Sensors 2020; 20(12): 3487 doi: 10.3390/s20123487
|
16 |
Byungho Lim, Jong-Hwan Kim, Mirang Kim, Seon-Young Kim. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1190-1201 doi: 10.3748/wjg.v22.i3.1190
|
17 |
Md Basar, Mohd Ahmad, Jongman Cho, Fatimah Ibrahim. Application of Wireless Power Transmission Systems in Wireless Capsule Endoscopy: An Overview. Sensors 2014; 14(6): 10929 doi: 10.3390/s140610929
|
18 |
Weipeng Lu, Mei Li, Hai Wang, Lina Liu, Shen Lu. An epidermal growth factor receptor exon 19 mutation in a mucin-producing gastric cancer sample from a Chinese patient. Japanese Journal of Clinical Oncology 2016; 46(6): 502 doi: 10.1093/jjco/hyw033
|
19 |
Tengyang Ni, Haibo Wang, Dongmei Zhan, Li Tao, Mengying Lv, Weimin Wang, Zewen Chu, Zhen Zhou, Masataka Sunagawa, Yanqing Liu. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features. Life Sciences 2021; 269: 119021 doi: 10.1016/j.lfs.2021.119021
|
20 |
Ramon Andrade De Mello. Gastric Cancer in Southern Europe: High-Risk Disease. American Society of Clinical Oncology Educational Book 2017; (37): 261 doi: 10.1200/EDBK_175227
|
21 |
B. Sushma. Sustainable Communication Networks and Application. Lecture Notes on Data Engineering and Communications Technologies 2021; 55: 275 doi: 10.1007/978-981-15-8677-4_23
|
22 |
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto, Kazuo Shirouzu. Molecular targeting to treat gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13741-13755 doi: 10.3748/wjg.v20.i38.13741
|
23 |
S. T. Kim, I.-G. Do, J. Lee, I. Sohn, K.-M. Kim, W. K. Kang. The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. Clinical and Translational Oncology 2015; 17(6): 462 doi: 10.1007/s12094-014-1258-7
|
24 |
Ramon Andrade de Mello, Jailson de Oliveira, Georgios Antoniou. Angiogenesis and Apatinib: A New Hope for Patients with Advanced Gastric Cancer?. Future Oncology 2017; 13(4): 295 doi: 10.2217/fon-2016-0318
|